News Teprotumumab Improves Bulging, QOL in Thyroid Eye Disease by Medscape • 2019/11/05 • 0 Comments The pooled results of phase 2 and 3 clinical trials could pave the way for first approved drug for thyroid eye disease. Medscape Medical News